Resmed (RMD) Other Non-Current Liabilities (2010 - 2026)

Resmed (RMD) has 17 years of Other Non-Current Liabilities data on file, last reported at $146.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 198.22% year-over-year to $146.1 million; the trailing twelve-month figure through Mar 2026 stood at $146.1 million (up 198.22% YoY), and the FY2025 full-year result was $141.5 million, up 234.9% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $146.1 million, up from $138.5 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $146.1 million in Q1 2026 and bottomed at $5.8 million in Q3 2022.
• The 5-year median for Other Non-Current Liabilities is $49.0 million (2025), against an average of $65.0 million.
• The widest annual swing landed in 2022, when Other Non-Current Liabilities slumped 89.04%; it then jumped 1179.09% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $37.2 million in 2022, then tumbled by 67.3% to $12.2 million in 2023, then retreated by 10.91% to $10.8 million in 2024, then surged by 1179.09% to $138.5 million in 2025, then gained by 5.44% to $146.1 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $146.1 million (Q1 2026), $138.5 million (Q4 2025), and $138.2 million (Q3 2025), per Business Quant data.

Peer Comparison